Orange Book product · Brand (NDA)
LANOXICAPS
DIGOXIN
At a glance
Sep 24, 1984
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 24, 1984
42 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
DIGOXIN
Strength
0.15MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 018118
Product number
004
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2004DIGOXINBrand (NDA)
NDA 021648 · HIKMA
- 1997LANOXINBrand (NDA)
NDA 020405 · ADVANZ PHARMA
- —LANOXINBrand (NDA)
NDA 009330 · AZURITY
- 2022DIGOXINGeneric (ANDA)
ANDA 215307 · NOVITIUM PHARMA
- 2022DIGOXINGeneric (ANDA)
ANDA 215209 · AMICI PHARMA
- 2022DIGOXINGeneric (ANDA)
ANDA 214982 · AUROBINDO PHARMA LTD
- 2019DIGOXINGeneric (ANDA)
ANDA 213000 · VISTAPHARM LLC
- 2009DIGOXINGeneric (ANDA)
ANDA 078556 · IMPAX LABS
- 2007DIGOXINGeneric (ANDA)
ANDA 077002 · HIKMA INTL PHARMS
- 2003DIGOXINGeneric (ANDA)
ANDA 040481 · SANDOZ
- 2003DIGOXINGeneric (ANDA)
ANDA 076363 · SUN PHARM INDS INC
- 2002DIGOXINGeneric (ANDA)
ANDA 076268 · STEVENS J
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
